Halozyme Therapeutics Inc. buy TD Cowen
Start price
18.02.26
/
50%
€61.94
Target price
18.02.27
-
Performance (%)
43.98%
Price
07.08.26
€89.18
Summary
This prediction is currently active. The BUY prediction by TD_Cowen for Halozyme Therapeutics Inc. has seen massive gains of 43.98%. This prediction currently runs until 18.02.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 24.588% | 24.588% |
| iShares Core DAX® | 2,57 % | 3,50 % |
| iShares Nasdaq 100 | 4,86 % | 0,65 % |
| iShares Nikkei 225® | 5,59 % | -0,25 % |
| iShares S&P 500 | 3,25 % | 2,08 % |
Comments by TD_Cowen for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "buy" rating reaffirmed by analysts at TD Cowen.
Ratings data for HALO provided by MarketBeat
Stopped prediction by TD_Cowen for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€89.18
07.08.26
07.08.26
€91.12
07.08.27
07.08.27
-
07.08.26
07.08.26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€62.16
08.01.26
08.01.26
€77.09
08.01.27
08.01.27
43.47%
07.08.26
07.08.26

